ProQR Therapeutics N.V. - PRQR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 06, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jan 20, 2026 | SCHEDULE 13G | STICHTING AESCAP LIFE SCIENCES | 3.9% | 4,156,878 | View |
| Jan 20, 2026 | SCHEDULE 13G | PRIVIUM FUND MANAGEMENT B.V. | 5.2% | 5,467,149 | View |
| Jan 20, 2026 | SCHEDULE 13G | STICHTING AESCAP GENETICS | 1.2% | 1,310,271 | View |
| Jan 20, 2026 | SCHEDULE 13G | INSPIRATIONAL VISIONS B.V. | 0.1% | 35,411 | View |
| Jan 20, 2026 | SCHEDULE 13G | PATRICK JOHAN HENDRIK KROL | 5.2% | 5,528,862 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.